Viking Therapeutics (VKTX) stock slips 1.48% despite reporting 21.9% revenue growth and 43.9% adjusted net income increase for 2025. Full analysis here. The post Viking Therapeutics (VKTX) Stock: Financial Performance Highlights 22% Revenue Growth and 44% Profit Increase in…